SchroderFH, DenisLJ, KirkelsW, de KoningHJB. European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam pilot studies.Cancer1995; 76: 129–34.
2.
GohaganJK, ProrokPC, KramerBS, HayesB, CornettJE. The Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial of the National Cancer Institute.Cancer1995; 76(suppl 7): 1869–73.
3.
NorlenBJ. Swedish randomised trial of radical prostatectomy versus watchful waiting.Can J Oncol1994; 4: 38–40.
4.
WiltTJ, BrawerMK. The Prostate Cancer Intervention Versus Observation Trial: a randomised trial comparing radical prostatectomy versus expectant management for the treatment of clinically localised prostate cancer.J Urol1994; 152: 1910–14.
5.
BostwickDG, PacelliA, Lopez-BeltranA.Molecular biology of prostatic intraepithelial neoplasia.Prostate1996; 29: 117–34.
6.
MontironiR, BostwickDG, BonkoffH.Origins of prostate cancer.Cancer1996; 78: 362–5.
7.
BostwickDG, QianJ.Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies.Am J Surg Pathol1995; 19: 506–18.
8.
BrawnPN, JohnsonEH, SpeightsVO.Long term surveillance of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.Br J Cancer1994; 69: 1098–101.
9.
KoviJ, MostofiFK, HeshmatMY, EnterlineJP. Large acinar atypical hyperplasia and carcinoma of the prostate.Cancer1988; 61: 555–61.
10.
QuinnBD, ChoKR, EpsteinJI. Relationship of severe dysplasia to stage B adenocarcinoma of the prostate.Cancer1990; 65: 2528–37.
11.
McNealJE, VillersA, RedwineEA, FreihaFS, StameyTA. Microcarcinoma in the prostate: its association with duct-acinar dysplasia.Hum Pathol1991; 22: 644–52.
12.
QianJ, BostwickDG. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.Pathol Res Pract1995; 191: 860–7.
13.
McNealJE, BostwickDG. Intraduct dysplasia: a premalignant lesion of the prostate.Hum Pathol1986; 17: 64–71.
14.
BostwickDG, AminMB, DundoreP, MarshW, SchulzDS. Architectural patterns of high grade prostatic intraepithelial neoplasia.Hum Pathol1993; 24: 298–310.
15.
AllamCK, BostwickDG, HayesJA.Interobserver variability in the diagnosis of high grade prostatic intraepithelial neoplasia and adenocarcinoma.Mod Pathol1996; 9: 742–51.
16.
EpsteinJI, GrignonDJ, HumphreyPA.Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia.Am J Surg Pathol1995; 19: 873–86.
17.
De La TorreM, HaggmanM, BrandstedtS, BuschC.Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: distribution, volumes and DNA ploidy.Br J Urol1993; 72: 207–13.
18.
BartelsPH, ThompsonD, MontironiR, MariuzziG, HamiltonPW. Automated reasoning system in histopathologic diagnosis and prognosis of prostate cancer and its precursors.Eur Urol1996; 30: 222–33.
19.
LeeF, Top-PedersenST, CarrollJT, SidersDB, Christensen-DayC, MitchellAE. Use of transrectal ultrasound and prostate-specific antigen in diagnosis of prostatic intraepithelial neoplasia.Urology1978; 34(suppl): 4–8.
20.
SakrWA, GrignonD, HaasGP, HeilbrunLK, PontesJE, CrissmanJD. Age and racial distribution of prostatic intraepithelial neoplasia.Eur Urol1996: 30: 138–44.
21.
TroncosoP, BabaianRJ, RoJY, GrignonDJ, Von EschenbachAC, AyalaAG. Prostatic intra-epithelial neoplasia and invasive prostatic adenocarcinoma in cystoprostatectomy specimens.Urology1989; 34(Suppl. 6): 52–6.
22.
Athanase BrillisA.Age and race distribution of high grade prostatic intraepithelial neoplasia (HGPIN): an autopsy study in Brazil (South America).Mod Pathol1996; 9: 71A.
23.
LangerJE, RovnerES, ColemanBG.Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy.J Urol1996; 155: 228–31.
24.
BrawerMK, BiglerSA, SohlbergOE, NagleRB, LangePH. Significance of prostatic intraepithelial neoplasia on prostate needle biopsy.Urology1991; 38(2): 103–7.
25.
KeetchDW, HumphreyP, StahlD, SmithDS, CatalonaWJ. Morphometric analysis and clinical followup of isolated prostatic intraepithelial neoplasia in needle biopsy of the prostate.J Urol1995; 154(2 Pt 1): 347–51.
26.
RonnettBM, CarmichaelMJ, CarterHB, EpsteinJI. Does high grade prostatic intraepithelial neoplasia result in elevated serumprostate specific antigen levels?J Urol1993; 150(2 Pt l): 486–9.
27.
AlexanderEE, QianJ, WollanPC, MyersRP, BostwickDG. Prostatic intraepithelial neoplasia does not appear to raise serum prostate-specific antigen concentration.Urology1997; 47: 693–8.
28.
WeinsteinMH, EpsteinJI. Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy.Hum Pathol1993; 24: 624–9.
29.
AboseifS, ShinoharaK, WeidnerN, NarayanP, CarrollPR. The significance of prostatic of prostatic intra-epithelial neoplasia.Br J Urol1995; 76(3): 355–9.
30.
DavidsonD, BostwickDG, QianJ.Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies.J Urol1995; 154(4): 1295–9.
31.
RavivG, JanssenT, ZlottaAR, DescampsF, VerhestA, SchulmanCC. Prostatic intraepithelial neoplasia. Influence of clinical and pathological data on the detection of prostate cancer.J Urol1996; 156: 1050–5.
32.
BrawerMK, RennelsMA, NagleRB, SoidererMH, LeeF.Prostatic intraepithelial neoplasia: a lesion that may be confused with cancer on prostatic ultrasound.J Urol1989; 142: 1510–12.
33.
BostwickDG, QianJ, FrankelK.The incidence of high grade prostatic intraepithelial neoplasia in needle biopsies.J Urol1995; 154(5): 1791–4.
34.
FeneleyMR, GreenJSA, YoungMPA.Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implications.Prostate Cancer Prostatic Dis (in press).
35.
BonkhoffH, RembergerK.Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model.Prostate1996; 28: 98–106.
36.
BonkhoffH, SteinU, RembergerK.The proliferative function of basal cells in the normal and hyperplastic human prostate.Prostate1994; 24: 114–18.
37.
BonkhoffH, RembergerK.Widespread distribution of nuclear androgen receptors in the basal cell layer of the normal and hyperplastic human prostate.Virchows Arch Pathol Pathol Anat1993; 442: 35–8.
38.
BrolinJ, SkookI, EkmanP.Immunohistochemistry and biochemistry in detection of androgen, progesterone and estrogen receptors in benign and malignant human prostatic tissue.Prostate1992; 20: 281–95.
39.
Di Sant'AgnesePA. Neuroendocrine differentiation in carcinoma of the prostate: diagnostic, prognostic and therapeutic implications.Cancer1992; 70: 254–68.
40.
DaviesP, EatonCL. Regulation of prostate growth.J Endocrinol1991; 131: 5–17.
41.
BonkhoffH, SteinU, RembergerK.Endocrine-paracrine cell types in the prostate and prostatic adenocarcinomas are postmitotic cells.Hum Pathol1995; 26: 167–70.
42.
QianJ, BostwickDG, TakahashiS.Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridisation.Cancer Res1995; 55: 5408–14.
43.
MontironiR, GalluzziCM, DiamantiL, GiannulisI, PisaniE, ScarpelliM.Prostatic intraepithelial neoplasia: expression and localization of proliferating cell nuclear antigen (PCNA) in epithelial, endothelial and stromal nuclei.Virchows Arch Pathol Pathol Anat1993; 422: 185–92.
44.
SakrWA, MacoskaJA, BensonP.Allelic loss in locally metastatic, multisampled prostate cancer.Cancer Res1994; 54: 3273–7.
45.
Emmerg-BuckMR, VockeCD, PozzattiRO.Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.Cancer Res1995; 55: 2959–62.
46.
WestinP, StattinP, DamberJE, BerghA.Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumours.Am J Pathol1995; 146: 1368–75.
47.
MontironiR, Magi GalluzziCM, MarinaS, DiamantiL.Quantitative characterization of the frequency and location of cell proliferation and death in prostate pathology.J Cell Biochem1994; 19: 238–45.
48.
ColombelM, SymmansF, GilS.Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers.Am J Pathol1993; 143: 390–400.
49.
KrajewskaM, KrajewskiS.Immunohistochemical analysis of bcl-2, bax, bcl-X and mcl-1 expression in prostate cancers.Am J Pathol1996; 148: 1567–76.
50.
MyersRB, OelschlagerD, ScrivastavaS, GrizzleWE. Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas.Prostate1994; 25: 243–8.
51.
MontironiR, Magi GalluziC, DiamantiL.Prostatic intraepithelial neoplasia. Qualitative and quantitative analyses of the blood capillary architecture on thin tissue sections.Pathol Res Pract1993; 189: 542–8.
52.
HellstromM, HaggmanM, BrandstedtS.Histopathological changes in androgen-deprived localized prostate cancer: a study in total prostatectomy specimens.Eur Urol1993; 24: 461–5.
53.
FergusonJ, ZinckeH, EllisonE, BergstrahlE, BostwickDG. Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy.Urology1994; 4: 91–5.